Filgrastim SD/01

DRUG2 trials

Sponsors

M.D. Anderson Cancer Center

Conditions

Hodgkin DiseaseNon-Hodgkin's Lymphoma

Phase 2

A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma

CompletedNCT00038545

M.D. Anderson Cancer CenterNon-Hodgkin's Lymphoma

Start: 2001-05-18End: 2004-04-27Updated: 2018-10-30

Phase 3

Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy

CompletedNCT00038558

M.D. Anderson Cancer CenterHodgkin Disease

Start: 2001-11-30End: 2005-03-31Updated: 2018-10-31